Medical Abortion: Self-Managed vs. Clinic Care
- Self-managed abortion using mifepristone and misoprostol is a safe and effective option for women in early pregnancy, according to a review of multiple studies.
- the review included 18 studies, consisting of two randomized controlled trials (RCTs) and 16 non-randomized studies (NRSs).
- Researchers found no significant difference in successful abortion rates between women who self-administered the medication and those who had it administered by a provider.
Self-Managed Abortion: Safe and Effective in Early Stages, Studies Show
Updated June 02, 2025
Self-managed abortion using mifepristone and misoprostol is a safe and effective option for women in early
pregnancy, according to a review of multiple studies. The research, encompassing over 11,000 women across 10
countries, found that outcomes are comparable to those of provider-managed abortions.The analysis focused on
early medical abortion, defined as up to nine weeks of gestation.
the review included 18 studies, consisting of two randomized controlled trials (RCTs) and 16 non-randomized
studies (NRSs). A significant portion of the research originated from low-to-middle income countries. The
typical scenario involved women taking mifepristone while in the presence of a healthcare provider, followed by
self-administration of misoprostol, frequently enough at home.
Researchers found no significant difference in successful abortion rates between women who self-administered
the medication and those who had it administered by a provider. Two RCTs showed a risk ratio of 0.99, while 16
NRSs yielded a similar result. These findings suggest that self-managed abortion is a viable option for
women seeking to terminate a pregnancy in its early stages.
Data also indicated little to no difference in ongoing pregnancy rates between the two groups. One RCT showed
a risk ratio of 1.69, while 11 NRSs reported a risk ratio of 1.28. However, the certainty of evidence was
rated as low to very low, indicating a need for further research.
The review noted uncertainty regarding complications requiring surgical intervention due to the lack of RCTs.Evidence from three NRSs was of very low certainty, making it challenging to draw definitive conclusions.
What’s next
further research, especially randomized controlled trials, could provide more definitive evidence regarding
the safety and efficacy of self-managed abortion, especially concerning potential complications. These studies
could help inform guidelines and policies related to abortion access and care.